|本期目录/Table of Contents|

[1]黄丽萍(综述),何斐(审校).人类肿瘤中竞争性内源性RNA的生物学调控作用[J].福建医科大学学报,2018,52(04):276-280.
点击复制

人类肿瘤中竞争性内源性RNA的生物学调控作用(PDF)
分享到:

《福建医科大学学报》[ISSN:1672-4194/CN:35-1192/R]

卷:
第52卷
期数:
2018年04期
页码:
276-280
栏目:
综述
出版日期:
2018-08-20

文章信息/Info

Title:
-
文章编号:
1672-4194(2018)04-0276-05
作者:
黄丽萍(综述) 何斐(审校)
福建医科大学 公共卫生学院 流行病与卫生统计学系,福州350108
Author(s):
-
关键词:
微RNAs 反应元件 RNA 肿瘤
Keywords:
-
分类号:
R342.2; R730.23
DOI:
-
文献标志码:
A
摘要:
-
Abstract:
-

参考文献/References:

[1]段纪俊,严亚琼,杨念念,等. 中国恶性肿瘤发病与死亡的国际比较分析[J]. 中国医学前沿杂志(电子版), 2016,8(7):17-23.
[2]Heery R,Finn S,Cuffe S,et al. Long Non-Coding RNAs: key regulators of epithelial-mesenchymal transition, tumour drug resistance and cancer stem cells[J]. Cancers, 2017,9(4):38-85.
[3]Kapranov P,Willingham A T,Gingeras T R. Genome-wide transcription and the implications for genomic organization[J]. Nature Reviews Genetics, 2007,8(6):413-423.
[4]Wang K C,Chang H Y. Molecular mechanisms of long noncoding RNAs[J]. Molecular Cell, 2011,43(6):904-914.
[5]Li L J,Zhao W,Tao S S,et al. Competitive endogenous RNA network: potential implication for systemic lupus erythematosus[J]. Expert Opin Ther Targets, 2017,21(6):639-648.
[6]Li J H,Liu S,Zhou H,et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data[J]. Nucleic Acids Research, 2014,42(Database issue):92-97.
[7]D’errico I,Gadaleta G,Saccone C. Pseudogenes in metazoa: origin and features[J]. Briefings in Functional Genomics & Proteomics, 2004,3(2): 157-167.
[8]Poliseno L. Pseudogenes: newly discovered players in human cancer[J]. Science Signaling, 2012,5(242):re5.
[9]Laura P,Leonardo S,Zhang J,et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology[J]. Nature, 2010,465(7301):1033-1038.
[10]Wang L,Guo Z Y,Zhang R,et al. Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma[J]. Carcinogenesis, 2013,34(8):1773-1781.
[11]Hayashi H,Arao T,Togashi Y,et al. The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer[J]. Oncogene, 2015,34(2):199-208.
[12]Yu G,Yao W,Gumireddy K,et al. Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression[J]. Molecular Cancer Therapeutics, 2014,13(12):3086-3097.
[13]Peng H,Ishida M,Li L,et al. Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR-17-5p in hepatocellular carcinoma[J]. Oncotarget, 2015,6(8):5666-5677.
[14]Salmena L,Poliseno L,Tay Y,et al. ceRNA hypothesis: The rsetta stone of a hidden RNA language[J]? Cell, 2011,146(3):353-358.
[15]Ms K,E A-M,P E,et al. HMGA2 functions as a competing endogenous RNA to promote lung cancer progression[J]. Nature, 2014,505(7482):212-217.
[16]Liu K,Guo L,Guo Y,et al. AEG-1 3’-untranslated region functions as a ceRNA in inducing epithelial-mesenchymal transition of human non-small cell lung cancer by regulating miR-30a activity[J]. European Journal of Cell Biology, 2015,94(1):22-31.
[17]李静秋,杨杰,周平,等. 竞争性内源RNA的生物学功能及其调控[J]. 遗传, 2015,37(8):756-764.
[18]李娜,田甜,李慧,等. 抑癌基因PTEN在恶性肿瘤中的研究进展[J]. 肿瘤研究与临床, 2016,28(8):568-573.
[19]Lee D Y,Jeyapalan Z,Fang L,et al. Expression of versican 3′-untranslated region modulates endogenous microRNA functions[J]. Plos One, 2010,5(10):e13599.
[20]Karreth F A,Tay Y,Perna D,et al. In vivo identification of tumor suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma[J]. Cell, 2011,147(2):382-395.
[21]Tay Y,Kats L,Salmena L,et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs[J]. Cell, 2011,147(2): 344-357.
[22]Yang J,Li T,Gao C,et al. FOXO1 3′UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity[J]. Febs Letters, 2014,588(17):3218-3224.
[23]Guo G,Kang Q,Zhu X,et al. A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA[J]. Oncogene, 2015,34(14):1768-1779.
[24]Dong R,Liu X Q,Zhang B B,et al. Long non-coding RNA-CRNDE: a novel regulator of tumor growth and angiogenesis in hepatoblastoma[J]. Oncotarget, 2017,8(26):42087-42097.
[25]Wang J,Liu X,Wu H,et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer[J]. Nucleic Acids Research, 2010,38(16):5366-5383.
[26]Xia T,Liao Q,Jiang X,et al. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer[J]. Scientific Reports, 2014,4:6088-6094.
[27]Gibb E A,Brown C J,Lam W L. The functional role of long non-coding RNA in human carcinomas[J]. Molecular Cancer, 2011,10(1):38-54.
[28]Liang W C,Fu W M,Wong C W,et al. The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer[J]. Oncotarget, 2015,6(26):22513-22525.
[29]Sun T,Wong N. Transforming growth factor-β-induced long noncoding RNA promotes liver cancer metastasis via RNA-RNA crosstalk[J]. Hepatology, 2015,61(2):722-724.
[30]Shen Y,Liu S,Yuan H,et al. A long non-coding RNA lncRNA-PE promotes invasion and epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-200a/b-ZEB1 pathway[J]. Tumour Biology the J the International Society for Oncodevelopmental Biology & Medicine, 2017,39(5):1010428317705756.
[31]Chen J H,Zhou L Y,Xu S,et al. Overexpression of lncRNA HOXA11-AS promotes cell epithelial-mesenchymal transition by repressing miR-200b in non-small cell lung cancer[J]. Cancer Cell International, 2017,17(1): 64-74.
[32]Paci P,Colombo T,Farina L. Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer[J]. BMC Systems Biology, 2014,8(1):83-97.
[33]Fan M,Xinying L I,Jiang W,et al. A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells[J]. Experimental & Therapeutic Medicine, 2013,5(4):1143-1146.
[34]Zhang Z,Zhu Z,Watabe K,et al. Negative regulation of lncRNA GAS5 by miR-21[J]. Cell Death & Differentiation, 2013,20(11):1558-1568.
[35]连瑜,李夏雨,唐艳艳,等. LncRNA作为ceRNA调控肿瘤的发生发展[J]. 生物化学与生物物理进展, 2016(3):219-225.
[36]Qu S,Yang X,Li X,et al. Circular RNA: A new star of noncoding RNAs[J]. Cancer Letters, 2015,365(2):141-148.
[37]Chen Y,Li C,Tan C,et al. Circular RNAs: a new frontier in the study of human diseases[J]. J Medical Genetics, 2016,53(6):359-365.
[38]Ping Y,Qiu Z,Yuan J,et al. Silencing of cZNF292 circular RNA suppresses human glioma tube formation via the Wnt/β-catenin signaling pathway[J]. Oncotarget, 2016,7(39):63449-63455.
[39]Su H,Lin F,Deng X,et al. Profiling and bioinformatics analyses reveal differential circular RNA expression in radioresistant esophageal cancer cells[J]. J Translational Medicine, 2016,14(1):225-234.
[40]Zhong Z,Lv M,Chen J. Screening differential circular RNA expression profiles reveals the regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in bladder carcinoma[J]. Scientific Reports, 2016,6:30919-30930.
[41]Hansen T B,Kjems J,Damgaard C K. Circular RNA and miR-7 in cancer[J]. Cancer Research, 2013,73(18):5609-5612.
[42]Huang G,Hua Z,Shi Y,et al. cir-ITCH Plays an inhibitory role in colorectal cancer by regulating the wnt/β-catenin pathway[J]. Plos One, 2015,10(6):e0131225.
[43]Yang W,Du W W,Li X,et al. Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis[J]. Oncogene, 2016,35(30):3919-3931.

相似文献/References:

[1]徐 燕,黄建航,郑志平,等.miR-383调控血管生成因子VEGFA的表达并抑制血管生成[J].福建医科大学学报,2019,53(02):71.
 XU Yan,HUANG Jianhang,ZHENG Zhiping,et al.miR-383 Regulates Angiogenic Gene VEGFA Expression and Inhibits Angiogenesis[J].Journal of Fujian Medical University,2019,53(04):71.

备注/Memo

备注/Memo:
收稿日期: 2017-11-21 基金项目: 国家自然科学基金(81402738);福建省自然科学基金(2015J01305, 2016J01355);福建省高校杰出青年科研人才培育计划(2017B019);国家重点研发计划支持项目(2017YFC0907100) 作者单位: 福建医科大学 公共卫生学院 流行病与卫生统计学系,福州350108 作者简介: 黄丽萍,女,福建医科大学流行病与卫生统计学2016级硕士研究生. Email:1059262936@qq.com
更新日期/Last Update: 1900-01-01